Market Tracker

01/20 5:16pm ET

PowerShares Dynamic Pharmaceuticals Portfolio (PJP)

Delayed Data
As of Jan 20
 -0.32 / -0.58%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 23 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

What Lies Ahead for Pharma ETFs?
Jan 19 / - Paid Partner Content


1 month-2.40% 3 years+2.56%
3 months-6.44% 5 years+16.33%
1 year-11.88% Since inception+13.57%
Data through 01/21/2017

Quote Details

Previous close$55.58
Open day’s range55.16 – 55.62
Net asset value (NAV)55.23 (01/20/2017)
Daily volume125,657
Average volume (3 months)157,876
Data as of 7:59pm ET, 01/20/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+16.33%+16.84%
Expense Gross exp ratio0.57%1.32%
Risk 5 year sharpe ratio1.041.08
Net assets$840.5M$2.8B
Average market cap$23.0B$32.0B
Average P/E18.419.5
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 97.52%
Consumer goods 2.48%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
LLY Eli Lilly and Co5.49%
BMY Bristol-Myers Squibb5.27%
PFE Pfizer5.25%
JNJ Johnson & Johnson5.18%
AMGN Amgen5.17%
AGN Allergan5.03%
PBH Prestige Brands Holdings Inc4.98%
CELG Celgene4.91%
GILD Gilead Sciences4.86%
MRK Merck4.86%